… launches Xkinash Plus Cream
An indigenous pharmaceutical company based in Lagos, Kuka Consumer Healthcare Limited (KCH), in partnership with Zheijiang Jingwei Pharmaceutical Co. Ltd China, last month in Lagos organised a media launch for the introduction of Xkinash plus cream, an antifungal brand of drug product into the Nigerian pharmaceutical market.
‘’It is a product of high quality designed for the treatment of skin disorders’’, Chris Ukah, Group Managing Director/Chief Executive Officer of the company said during the launching which took place at the corporate headquarters of KCH in the Gbagada area of Lagos.
He explained that the product is a 4-way action drug cream because it has Antifungal, Antibacterial, Anti-inflamatory and Antipruritic capabilities in addressing common skin related diseases. According to him, Xkinash plus comes in a 20g tube white to off white cream adding that it has little or no side effects when used properly, but also warned that special precautions must be observed during use by pregnant mothers and children.
On the partnership with Zheijiang Jingwei Pharmaceutical Co. Ltd., the KCH boss said that the Chinese company is a top rated pharmaceutical group ‘’entitled as National Key Hi-tech Enterprise, National Pilot Enterprise of Innovation, and China’s top 500 private enterprises’’. The company, he said, produced Xkinash plus cream after extensive research spanning over 3 years and subjected the drug to international best practices in pharmaceutical quality control analysis.
Ukah who spoke on the pharmacological composition of the cream, explained that its potent activity is against: Candida albicans, Coccidiodes immites, Blastomyces dermatitidis and Microsporum Canis. Xkinash plus cream, he also explained, is indicated for the topical treatment of the following fungal infections of the skin: Tinea Manus, Tinea Pedis, Tinea Corporis, Tinea Cruris, Tinea Versicolor, and Dermatitis.
While declaring that the product is available in all pharmacy stores across the country, the KCH boss also disclosed that the drug product is registered with National Agency for Food and Drug Administration and Control (NAFDAC) adding that its genuineness is guaranteed by the Mobile Authentication System [MAS] security label each packet carries.